CD133 knockdown increased the nuclear translocation of DNMT1 in CD133+ glioma cells without obviously changing the nuclear translocation of DNMT3a or DNMT3b (Figure 2D and Figure S2F, Supporting Information). Here, DNMT3A is linked to central nervous system cancer.